CORRECTION article

Front. Pharmacol., 07 August 2025

Sec. Neuropharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1674993

Correction: Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update

  • 1. Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia

  • 2. Department of Biological Sciences, Sunandan Divatia School of Science, Narsee Monjee Institute of Management Studies (NMIMS), Mumbai, India

  • 3. Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia

  • 4. Department of Biotechnology, UNESCO Regional Centre for Biotechnology, Government of India, Faridabad, Haryana, India

  • 5. Manipal Institute of Regenerative Medicine (MIRM), Manipal Academy of Higher Education (MAHE), Bangalore, Karnataka, India

  • 6. Integrative Multiomics Lab, School of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India

  • 7. School of Pharmaceutical Sciences (Faculty of Pharmacy), IFTM University, Moradabad, Uttar Pradesh, India

In the published article, there was an error. A correction has been made to the Acknowledgments. This previously stated:

“The authors would like to humbly acknowledge the management of Monash University (Malaysia Campus) and Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS), supporting her overall academic and research pursuits. Authors would like to gratefully acknowledge Sagnik Nag, from JCSMHS MUM, for his continued intellectual support and motivation. The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through Large Research Project under grant number RGP2/316/46.”

The corrected statement appears below:

“The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through Large Research Project under grant number RGP2/316/46.”

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

nanomaterial-conjugated regenerative therapy, neurodegenerative disorders, nanomedicine, scaffold, neuroprotective-nanotechnology stem-cell therapy, nanotechnology

Citation

Chengebroyen N, Seelan A, Thajudeen KY, Alshehri SA, Biswas A, Adur I, Sundararajan V, Sudhakaran SL and Singh H (2025) Correction: Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments – a state-of-the-art update. Front. Pharmacol. 16:1674993. doi: 10.3389/fphar.2025.1674993

Received

28 July 2025

Accepted

30 July 2025

Published

07 August 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Neevashini Chengebroyen, ; Harpreet Singh, ; Vino Sundararajan,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics